10.52 0.51 (5.09%) | 07-26 16:00 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 12.49 ![]() |
1-year : | 14.59 ![]() |
Resists | First : | 10.69 ![]() |
Second : | 12.49 ![]() |
Pivot price | 9.14 ![]() |
|||
Supports | First : | 8.04 ![]() |
Second : | 6.4 ![]() |
MAs | MA(5) : | 9.9 ![]() |
MA(20) : | 8.78 ![]() |
MA(100) : | 8.08 ![]() |
MA(250) : | 6.32 ![]() |
|
MACD | MACD : | 0.6 ![]() |
Signal : | 0.4 ![]() |
%K %D | K(14,3) : | 91.3 ![]() |
D(3) : | 92 ![]() |
RSI | RSI(14): 80.5 ![]() |
|||
52-week | High : | 10.82 | Low : | 4.21 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SIGA ] has closed above the upper band by 0.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 12.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 10.71 - 10.74 | 10.74 - 10.77 |
Low: | 10.08 - 10.11 | 10.11 - 10.16 |
Close: | 10.45 - 10.51 | 10.51 - 10.58 |
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Fri, 26 Jul 2024
(SIGA) Technical Data - Stock Traders Daily
Fri, 26 Jul 2024
SIGA Technologies (SIGA) to Release Quarterly Earnings on Thursday - MarketBeat
Thu, 25 Jul 2024
SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results - GlobeNewswire
Thu, 25 Jul 2024
SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results - StockTitan
Thu, 25 Jul 2024
SIGA Technologies Target of Unusually Large Options Trading (NASDAQ:SIGA) - Defense World
Wed, 24 Jul 2024
Siga Technologies Inc. (SIGA) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
Shares Out | 71 (M) |
Shares Float | 40 (M) |
Held by Insiders | 43.3 (%) |
Held by Institutions | 49.2 (%) |
Shares Short | 5,580 (K) |
Shares Short P.Month | 5,120 (K) |
EPS | 1.1 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 2.31 |
Profit Margin | 50.4 % |
Operating Margin | 44.3 % |
Return on Assets (ttm) | 28.3 % |
Return on Equity (ttm) | 48.4 % |
Qtrly Rev. Growth | 205.5 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 2.2 |
EBITDA (p.s.) | 1.37 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 64 (M) |
Levered Free Cash Flow | 93 (M) |
PE Ratio | 9.56 |
PEG Ratio | 7.3 |
Price to Book value | 4.53 |
Price to Sales | 4.76 |
Price to Cash Flow | 11.64 |
Dividend | 0.6 |
Forward Dividend | 0 |
Dividend Yield | 5.7% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |